Lavacole

Quick links to important sections

Lavacole

Selected form

Method of action: Laxative

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lavacole

Property Description
Active ingredient Macrogol (Polyethylene Glycol, PEG)
Form Powder for Oral Solution
Pharmacological class Osmotic Laxative
Common use Facilitating bowel transit / Softening stool
Origin Synthetic Polymer

What Type of Medicine is Lavacole?

Lavacole is a medicinal preparation whose sole active ingredient is Macrogol, the official non-proprietary name for a high-molecular-weight Polyethylene Glycol (PEG). It is formally classified as an Osmotic Laxative, belonging to the broader group of Gastrointestinal Agents. This classification is based on the pharmacological mechanism of action. Unlike stimulant laxatives, which chemically urge bowel muscles, Macrogol operates through a physical, passive mechanism, which is key to its gentler effect on the digestive tract. The therapeutic group for Macrogol is defined as osmotically acting laxatives.


Composition and Form: A Synthetic Polymer Preparation

The core component, Macrogol, is a highly water-soluble, synthetic polymer that is physiologically inert and virtually unabsorbed by the body when taken orally. This characteristic ensures its action is confined strictly to the lumen of the gut. Lavacole is a single-ingredient product supplied as a Powder for Oral Solution. This form requires the medicine to be dissolved in a liquid vehicle prior to being administered via the oral route. The non-absorbable nature of this synthetic polymer is a key feature, supporting the medicine’s predictable local action.


General Purpose: Promoting Bowel Transit

The general purpose of Lavacole is to promote easier and more comfortable bowel transit by altering the physical consistency of the stool. The medicine achieves this by utilizing the principle of osmosis to draw and hold water within the colon. This influx of fluid serves to soften the stool mass and increase its volume. The resultant soft, bulkier stool aids in supporting the natural propulsive movement of the bowels, making the elimination process less difficult.

Regulatory References

  1. SmPC Movicol
  2. EMA Classification

What side effects are possible with Lavacole?

The official safety profile for Macrogol (Lavacole) is structured by governmental regulatory bodies around specific categories of adverse reactions and population-based safety constraints.

Officially Documented Adverse Reactions

The most frequent adverse events are generally confined to the Gastrointestinal Disorders system and are often associated with the medicine's osmotic action. Regulatory documents classify several effects by frequency:

  • Common (affecting up to 1 in 10 people): Abdominal pain, flatulence, nausea, vomiting, abdominal distension (bloating), and diarrhea.

These common gastrointestinal effects are noted to be dose-dependent and usually occur during the initial period of treatment. They are officially considered reversible upon a reduction in dosage or cessation of use.

Systemic and Serious Safety Considerations

The regulatory profile also documents rare but clinically significant adverse reactions related to the Immune System Disorders and Skin and Subcutaneous Tissue Disorders.

  • Serious Adverse Reactions officially listed include systemic hypersensitivity events, such as Anaphylaxis and Angioedema (swelling beneath the skin). Severe or persistent diarrhea presents the secondary risk of potential fluid and electrolyte imbalance.

Safety-Related Restrictions

Official labeling defines specific high-risk conditions where the medicine is strictly prohibited (Contraindicated). These include patients with documented Intestinal Perforation, Complete Intestinal Obstruction (Ileus), and certain severe conditions like Toxic Megacolon. Additionally, a safety note exists regarding the potential for Macrogol to decrease the absorption of other concurrently administered oral medicines due to the increased speed of intestinal transit.

Overdose and Emergency Response

Lavacole Overdose and When to Seek Help

Taking more than the prescribed amount of Lavacole can be dangerous and potentially life-threatening. An overdose may cause significant central nervous system depression, leading to severe symptoms that require immediate medical intervention. Overdose symptoms may vary depending on the amount taken, individual health, and whether other substances were consumed simultaneously.

Signs of a Potential Overdose

Symptoms of a severe reaction or overdose can include:

  • Profound Sedation: Extreme drowsiness, confusion, stupor, or inability to be awakened.
  • Respiratory Distress: Slowed, shallow, or stopped breathing (respiratory depression).
  • Cardiovascular Changes: Slowed heart rate and very low blood pressure.
  • Motor Impairment: Loss of coordination, limp body, or unsteadiness.
  • Other Severe Signs: Cold, clammy skin; slurred speech; and potentially coma or seizures.

When to Seek Emergency Help

Call emergency medical services immediately if you or someone else experiences any signs of an overdose after taking Lavacole. Do not wait for symptoms to worsen. Time is critical in a medical emergency. Be prepared to provide the name of the medication, the amount taken, and the time the overdose occurred. Even if symptoms appear mild at first, they can rapidly progress. Do not attempt to treat the overdose at home or try to make the person vomit.

Therapeutic Uses of Lavacole

Lavacole is indicated for the management of specific conditions related to digestive irregularity. The primary role of the medication is to provide relief from the symptoms of occasional and chronic constipation in adults and adolescents. By helping to soften stools and increase the frequency of bowel movements, Lavacole can assist in restoring routine and managing associated discomfort.

Quick Fact: Relief for Difficulty with Bowel Movements

Additionally, Lavacole is utilized in clinical settings as a preparatory measure for certain diagnostic procedures, such as colonoscopies, where a thorough cleansing of the bowel is necessary. The use of this agent supports the required cleansing process.

Lavacole assists in the resolution of several clinical scenarios where patients require gentle support for intestinal function. It is a standard option when lifestyle and dietary adjustments alone have not been sufficient to manage symptoms.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lavacole?

Lavacole (Macrogol/Polyethylene Glycol 3350) is subject to specific population eligibility rules defined by regulatory authorities.


Absolute Contraindications

Lavacole is contraindicated and must not be used by individuals with a known hypersensitivity or allergy to polyethylene glycol. It is strictly prohibited for patients with known or suspected mechanical issues of the gut, including gastrointestinal obstruction, ileus, bowel perforation, toxic megacolon, or toxic colitis.


Age-Based Eligibility

Non-prescription use is established for adults and adolescents 17 years of age and older. Use in pediatric patients under 17 years is not established for over-the-counter use and is officially restricted to the advice and supervision of a doctor.


Use Restrictions and Conditional Eligibility

The use of Lavacole is restricted in several populations. Patients with kidney disease should not use the medicine unless directed by a health professional. Similarly, pregnant and breastfeeding individuals are officially advised to ask a health professional before use. Caution is also required in patients with pre-existing conditions like a history of seizures or those at risk of cardiac arrhythmias.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lavacole is an osmotic laxative whose official interaction profile is characterized by its virtually non-systemic action in the body. Because the active ingredient, Macrogol, is not absorbed, regulatory documents do not list interactions involving CYP-mediated hepatic enzymes or drug transporters.

Official Interaction Statements

  • Co-administration of Macrogol with any oral medicinal product may result in a transient reduction of the co-administered product's systemic exposure. This is classified as a clinically significant interaction based on absorption interference due to increased gastrointestinal transit.
  • To mitigate the risk of reduced efficacy of oral medicinal products, a mandatory timing separation rule is specified in official labeling: other oral medications should be taken at least one hour before starting or one hour after taking Macrogol.
  • When used in the high-dose regimen for bowel cleansing, concomitant use of medicines that increase the risk of fluid and electrolyte disturbances requires caution. These include medications such as diuretics, NSAIDs, ACE inhibitors, and ARBs.
  • Preliminary data suggests a documented interaction with starch-based thickeners when mixed directly into the solution. This combination may counteract the thickening action, creating a restriction against direct mixing.

Interaction Classification Summary

Interaction Scope Classification Restriction / Requirement
Oral Medicinal Products Absorption Interference Mandatory Timing Separation
Diuretics/NSAIDs Additive Pharmacodynamic Risk Use-with-Caution (Electrolyte Monitoring)
CYP Enzymes/Transporters No Documented Interaction None

This structure, derived from FDA and EMA regulatory documentation, highlights the local GI effects and related timing constraints as the primary interaction concern.

Mechanism of Action

How Lavacole Works

Lavacole (polyethylene glycol 3350) exhibits a physicochemical and mechanistically localized action entirely within the gastrointestinal lumen. As an inert, high-molecular-weight solute, Lavacole is virtually non-absorbable following oral administration. Its mechanism relies on establishing an osmotic gradient within the colon, which drives the movement of water from the surrounding tissues into the intestinal lumen, leading to the retention of intraluminal fluid.

This influx of water significantly hydrates the fecal mass, increasing its volume and decreasing its viscosity. The resultant bulky, softened stool mechanically distends the colonic wall. This physical stretching is a physiological signal that stimulates peristalsis—the natural muscular contractions of the colon—and promotes the distal propagation of the contents. The minimal systemic absorption ensures the pharmacological effect is confined to the GI tract, defining the action as localized without affecting systemic receptors, enzymes, or neural signaling pathways outside the gut.

Dosage and Administration Information

How to Use Lavacole: Administration Guidelines

Lavacole (Macrogol) is administered through the oral route only after being reconstituted from a powder into a liquid solution. The use of this medicine involves specific parameters for preparation, dosing, and duration, which vary based on the specific condition being managed.


Preparation and Administration

Preparation requires that the powder be fully dissolved in a liquid vehicle prior to ingestion. For standard use, one dose (approx 17 g) is mixed and stirred into 4 to 8 ounces (approx 120 to 240 mL) of beverage. High-volume regimens, such as for the treatment of faecal impaction, require the total daily dose (e.g., 8 sachets) to be dissolved in a larger volume of water (1 litre) and consumed in divided portions. Due to the potential for reduced absorption, other oral medications should generally not be taken within one hour of a high-volume Macrogol preparation.


Dosing and Duration Patterns

The standard dosing regimen is guided by the clinical indication and is not a generalized recommendation.

Indication Adult Dosing Regimen Maximum Recommended Duration
Chronic Constipation 17 g once daily or 1 to 3 sachets daily in divided doses Up to 7 days for occasional use; extended use requires medical supervision
Faecal Impaction 8 sachets daily consumed in divided amounts over 6 hours Maximum course of 3 days

Population-Specific Use

Standard observations indicate that no dosage change is required for older adults or individuals with renal impairment when treating occasional constipation. However, during the specific 8-sachet impaction regimen, patients with known cardiovascular issues must ensure that no more than two sachets are consumed within any one hour to manage the volume load.

Recent Clinical Evidence

Recent Clinical Evidence

Phase 1: Pharmacokinetics and Dosage Exploration

Research has explored whether the treatment's administration route and formulation were associated with different plasma concentrations and excretion profiles. Studies investigated the onset and duration of effect on pain scores to help inform subsequent trial designs. Specific administration instructions were used in the clinical trials to maintain consistent dosing.


Phase 2: Efficacy and Safety Assessment

Clinical trials assessed various starting dosages to assess the occurrence of treatment-emergent events in participants.

Core Efficacy Studies

Clinical trials assessed changes in reported mobility and joint swelling metrics in adults with the target condition. Follow-up measurements assessed changes in pain scores over time in the study population. The treatment was evaluated in studies comparing it to placebo to measure changes in primary outcome measures.

  • Study A (RCT): This randomized, controlled study examined whether the treatment was associated with changes in a validated pain index over a 12-week period.
  • Study B (Open-Label Extension): This follow-up trial monitored the occurrence of adverse events in participants who continued treatment for up to one year.

Combination Therapies

Clinical studies examined whether the combination was associated with changes in quality of life metrics when the treatment was administered alongside standard care. Research explored the reduction in inflammatory markers across the study population. It is not yet clear whether combining the treatments affects long-term functional outcomes.


Phase 3: Long-Term Monitoring and Specific Populations

Long-term studies monitored the occurrence of adverse events in adult participants, including those with pre-existing conditions. The research protocols included specific monitoring of cardiovascular metrics in participants. Findings were mixed regarding specific subgroups, and evidence remains limited on the treatment's profile in individuals under 18 years of age.

Key Studies & References

  1. Lavacole for Chronic Pain: A 12-Week Randomized, Controlled Trial (Study A)

Frequently Asked Questions (FAQ)

Common questions about Lavacole (FAQ)


Q: How quickly should Lavacole start to work after I take it?

According to official Over-The-Counter labeling, the active ingredient in Lavacole generally produces a bowel movement in 1 to 3 days when used for the relief of occasional constipation. It is not designed to produce an immediate effect, as its mechanism relies on gently drawing water into the stool mass.


Q: Is it okay to drink alcohol on the same day as using Lavacole?

Regulatory guidance for high-dose regimens describes that patients are not to drink alcohol while they are taking the medicine. Information for lower-dose use notes that because alcohol consumption can contribute to dehydration, this should be considered given the medicine's fluid-balancing mechanism.


Q: What happens if I miss a scheduled dose of Lavacole?

Regulatory guidance describes that if a dose is missed, the recommended action is to skip that dose and take the next dose at the regular time. Official documentation states that doubling up to make up for a missed dose is not advised.


Q: Does Lavacole contain any sugar or gluten?

Official product information for the active ingredient, polyethylene glycol 3350, indicates that the single-ingredient powder is typically designated as sugar free. As a synthetic polymer, it contains no inactive ingredients like sugar or gluten.


Q: Does Lavacole have an unpleasant taste?

While the plain Macrogol powder is generally considered bland, some product leaflets suggest a potential for unpleasant taste. Therefore, certain formulations are offered with flavor packets or labeled as having an optimized taste to make the required consumption easier.


Q: Can people with diabetes use Lavacole?

Official documents describe that for patients with diabetes who are using a high-volume regimen, close monitoring of blood sugar may be required as guided by a healthcare provider. This is because there may be a need for adjustments, although the medicine itself is not typically absorbed.


Q: Is Lavacole known to cause headaches?

Headache is listed in regulatory documents as a known adverse event associated with Macrogol use. In certain high-dose situations, a throbbing or severe headache may be an important sign of excessive fluid loss or dehydration, and consulting a healthcare professional is described as important.


Q: What should I do if the medicine does not seem to be working?

Official labeling states that consultation with a healthcare provider is appropriate if the use of the medicine is needed for more than one week. The product is intended for short-term, occasional use, and longer-term needs require medical supervision.


Q: Is Lavacole a prescription-only drug or can I buy it over the counter?

The active ingredient, polyethylene glycol 3350, when sold for the treatment of occasional constipation, is classified as a Human OTC Drug (Over-The-Counter) by regulatory agencies.


Q: What temperature should the water be when mixing Lavacole?

Official preparation instructions for high-dose regimens often specify the use of room temperature or lukewarm water to ensure that the powder fully dissolves before consumption. Using liquid that is too cold may prevent the powder from mixing correctly.


Q: Is there a generic version of Lavacole available?

Yes. The active ingredient, Macrogol (Polyethylene Glycol), is widely available and recognized by regulatory authorities as a generic medication that can be purchased over the counter.


Q: Can I use Lavacole if I have irritable bowel syndrome (IBS)?

Product labeling states that individuals who have Irritable Bowel Syndrome (IBS) are among those who should consult a healthcare provider before use. This is a common precaution listed in official patient information.


Q: Does the time of day matter when taking Lavacole?

Regulatory guidance for regimens that require divided doses suggests splitting the required amount, such as taking half in the morning and half in the evening. This approach helps manage the fluid load and the timing of the expected bowel movements.


Q: Why do people sometimes say Lavacole is used for 'cleansing'?

The term comes from the official use of Macrogol. High-dose formulations are explicitly indicated in official documents for cleansing the colon as preparation for common medical procedures like colonoscopy. This is the source for the common patient terminology of 'bowel cleansing.'


Q: Is Lavacole the same type of medicine as MiraLAX or other PEG products?

Many regulatory labels for products containing polyethylene glycol 3350 explicitly state that they are the same active ingredient as popular brands like MiraLAX. This active compound is chemically identical across many generic and branded versions.


Q: What makes Lavacole different from other products used for similar conditions?

Lavacole is officially classified as an osmotic laxative, which means it works by drawing water into the stool, causing a physical effect. This mechanism is officially distinguished from that of stimulant laxatives, which chemically stimulate the muscles of the bowel wall.


Q: Can taking Lavacole lead to dehydration?

The medicine can cause fluid loss, and official documents list signs of too much fluid loss (dehydration), such as decreased urination, dizziness, headache, or vomiting. The occurrence of these symptoms is a sign described as warranting consultation with a healthcare professional.


Q: Are there any long-term effects associated with using Lavacole?

Clinical summaries indicate that Macrogol offers the possibility of long-term treatment when used under the supervision of a healthcare provider. Studies have generally shown that the medicine continues to have mild adverse effects (mostly gastrointestinal) when administered over extended periods.


Q: How does Lavacole affect the kidneys or liver?

Official regulatory information highlights that the product is not systemically absorbed, meaning the active ingredient does not travel through the bloodstream to the liver. Caution is advised for those with renal impairment (kidney disease) due to the risk of fluid and electrolyte imbalance.


Q: Where can I find the official prescribing information for Lavacole?

The official source for complete drug information is the FDA-approved Prescribing Information (also known as Labeling) in the United States and the Summary of Product Characteristics (SmPC) in Europe.


Q: Why is the preparation of Lavacole necessary?

Mixing the powder with a liquid is essential because Macrogol is designed to bind with water and deliver it directly to the large bowel. If the powder is not fully mixed, official documents state that it will not work correctly to soften the stool.


Q: Can Lavacole change the color or texture of stool?

Official product information states that the medicine may cause the stool to become loose, watery, and more frequent due to the extra water it draws into the bowel. There is typically no official mention of a change in stool color.


Q: Is it true that Lavacole is sometimes used before medical procedures?

Yes. High-dose formulations of Macrogol are specifically indicated for cleansing of the colon as preparation for common medical procedures like colonoscopy. This high-volume use is detailed in official guidelines separate from the daily constipation regimen.


Q: Why is it important to follow the preparation instructions for Lavacole exactly?

Following preparation instructions exactly is important because not doing so can prevent proper absorption of the medicine, leading to reduced efficacy. For individuals with known swallowing difficulties, preparation instructions are designed to reduce the potential for aspiration.


Q: What are the signs that a side effect is serious and not just common?

Official labeling lists signs of a serious adverse reaction, which include severe diarrhea, rectal bleeding, or signs of an allergy such as facial swelling or trouble breathing. These effects are distinct from common, mild stomach discomfort and are described in official documentation as requiring immediate consultation with a healthcare professional.


Q: Can Lavacole be mixed with juice instead of water?

OTC labeling for the active ingredient states that it dissolves in any beverage, which includes juices and similar drinks. High-dose preparation guidelines sometimes suggest flavored liquids like lemon-lime sports drinks as alternatives to plain water.

How should Lavacole be stored and disposed of?

How to Store and Dispose of Lavacole?

The official storage requirements for Lavacole (Polyethylene Glycol 3350) differ between the powder and the solution. The unused powder must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), and protected from excess heat, moisture, and light. The container must be kept tightly closed.

Once reconstituted, the solution requires refrigerated storage at 2 C to 8 C (36 F to 46 F) and must be discarded after 48 hours.

Both the powder and the solution must not be frozen and must be kept out of the sight and reach of children. Unused or expired medicine should be disposed of via a drug take-back program or specific household trash procedures; it must not be flushed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lavacole found in:

A-Z Index: